Table 1.
Baseline characteristics.
Table 2.
Clinical characteristics and laboratory data.
Table 3.
Association between lipid and glucose parameters and ANGPTL3, 4, and 8.
Fig 1.
The relationship between TG levels and the four groups created using the median concentrations of ANGPTL3 and ANGPTL8.
Subjects were divided into four groups based on the median concentrations of ANGPTL3 and ANGPTL8 as follows: group 1, both ANGPTL3 and ANGPTL8 concentrations were higher than the median (ANGPTL3 ≥ 349.7 ng/mL, ANGPTL8 ≥ 49.8 pmol/L); group 2, the concentration of ANGPTL3 was below the median and that of ANGPTL8 was above the median (ANGPTL3 < 349.7 ng/mL, ANGPTL8 ≥ 49.8 pmol/L); group 3, the concentration of ANGPTL3 was above the median and that of ANGPTL8 was below the median (ANGPTL3 ≥ 349.7 ng/mL, ANGPTL8 < 49.8 pmol/L); and group 4, both ANGPTL3 and ANGPTL8 concentrations were below the median (ANGPTL3 < 349.7 ng/mL, ANGPTL8 < 49.8 pmol/L). Comparisons among the four groups were performed via Tukey’s multiple comparison test after adjusting for BMI. TG, triglycerides; ANGPTL, angiopoietin-like protein.
Table 4.
The relationship between lipid profiles and the four groups created using the median concentrations of ANGPTL3 and ANGPTL8.
Table 5.
Univariate and multivariate linear regression analyses of plasma TG levels and factors affecting TGs.